Haemonetics Corporation HAE
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/27/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.11% | 0.44% | -1.97% | -4.02% | -2.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.11% | 0.44% | -1.97% | -4.02% | -2.45% |
| Cost of Revenue | 2.64% | -2.05% | -7.61% | -13.78% | -11.18% |
| Gross Profit | 5.13% | 2.25% | 2.34% | 3.83% | 4.67% |
| SG&A Expenses | 7.45% | 2.63% | 3.10% | 0.97% | 0.83% |
| Depreciation & Amortization | -8.83% | -9.27% | -8.83% | -5.46% | 9.58% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.85% | -0.66% | -3.39% | -7.00% | -4.72% |
| Operating Income | 5.27% | 5.64% | 4.85% | 10.93% | 9.06% |
| Income Before Tax | -34.59% | -38.04% | -39.63% | 37.89% | 36.67% |
| Income Tax Expenses | -22.11% | -27.64% | -30.79% | 49.15% | 39.57% |
| Earnings from Continuing Operations | -38.22% | -41.05% | -41.97% | 34.88% | 35.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.22% | -41.05% | -41.97% | 34.88% | 35.84% |
| EBIT | 5.27% | 5.64% | 4.85% | 10.93% | 9.06% |
| EBITDA | 2.50% | 2.54% | 2.36% | 7.30% | 8.28% |
| EPS Basic | -34.22% | -37.48% | -38.95% | 42.51% | 41.49% |
| Normalized Basic EPS | 5.41% | 8.55% | 0.67% | 14.36% | 5.87% |
| EPS Diluted | -34.86% | -37.68% | -39.03% | 43.25% | 42.27% |
| Normalized Diluted EPS | 4.93% | 8.83% | 1.20% | 14.99% | 6.56% |
| Average Basic Shares Outstanding | -5.79% | -6.31% | -6.26% | -5.53% | -4.04% |
| Average Diluted Shares Outstanding | -5.48% | -6.57% | -6.75% | -6.04% | -4.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |